Dr. Ebere Chukwu, MD
NPI: 1093908535
Total Payments
$111,638
2024 Payments
$6,332
Companies
18
Transactions
202
Medicare Patients
571
Medicare Billing
$99,253
Payment Breakdown by Category
Other$89,825 (80.5%)
Travel$8,592 (7.7%)
Consulting$7,220 (6.5%)
Food & Beverage$5,886 (5.3%)
Education$115.75 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $89,825 | 39 | 80.5% |
| Travel and Lodging | $8,592 | 38 | 7.7% |
| Consulting Fee | $7,220 | 2 | 6.5% |
| Food and Beverage | $5,886 | 120 | 5.3% |
| Education | $115.75 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $56,896 | 60 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $41,641 | 47 | $0 (2024) |
| Lilly USA, LLC | $7,615 | 6 | $0 (2024) |
| Abbott Laboratories | $1,702 | 30 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,078 | 2 | $0 (2018) |
| ABIOMED | $897.11 | 9 | $0 (2024) |
| CVRx, Inc. | $383.23 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $326.82 | 9 | $0 (2024) |
| Novo Nordisk Inc | $305.89 | 6 | $0 (2024) |
| PFIZER INC. | $263.14 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,332 | 31 | Lilly USA, LLC ($3,740) |
| 2023 | $48,717 | 63 | Alnylam Pharmaceuticals Inc. ($35,662) |
| 2022 | $33,410 | 50 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18,310) |
| 2021 | $18,599 | 38 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,193) |
| 2020 | $2,520 | 4 | Alnylam Pharmaceuticals Inc. ($2,482) |
| 2019 | $615.92 | 9 | Abbott Laboratories ($375.06) |
| 2018 | $1,331 | 5 | Medtronic Vascular, Inc. ($1,078) |
| 2017 | $113.86 | 2 | ABIOMED ($102.37) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $104.71 | General |
| Category: Heart Failure | ||||||
| 12/07/2024 | Alnylam Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $129.48 | General |
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Travel and Lodging | Cash or cash equivalent | $276.20 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $107.03 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $101.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $119.74 | General |
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $107.17 | General |
| Category: Obesity | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $182.85 | General |
| Category: Heart Failure | ||||||
| 05/14/2024 | Analog Devices Inc. | Sensinel CPM Wearable (Device) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: CARDIOLOGY | ||||||
| 04/10/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Cardiology | ||||||
| 03/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $336.59 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $185.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 81 | 135 | $35,315 | $12,385 |
| 2022 | 8 | 192 | 341 | $99,934 | $28,171 |
| 2021 | 5 | 152 | 314 | $71,848 | $27,534 |
| 2020 | 5 | 146 | 359 | $86,352 | $31,163 |
Total Patients
571
Total Services
1,149
Medicare Billing
$99,253
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 57 | 100 | $28,000 | $10,253 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 24 | 35 | $7,315 | $2,133 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 74 | 133 | $37,240 | $13,537 | 36.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 82 | $16,482 | $6,263 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 28 | 35 | $7,315 | $2,491 | 34.1% |
| 93505 | Biopsy of heart muscle | Facility | 2022 | 11 | 14 | $15,778 | $2,167 | 13.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $4,389 | $1,470 | 33.5% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 11 | 12 | $8,568 | $1,084 | 12.7% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2022 | 13 | 31 | $8,184 | $938.55 | 11.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 18 | 23 | $1,978 | $220.12 | 11.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 67 | 144 | $40,320 | $15,480 | 38.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 68 | $13,668 | $5,498 | 40.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 61 | $8,479 | $3,347 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 27 | $5,643 | $1,712 | 30.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 14 | $3,738 | $1,497 | 40.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 65 | 155 | $43,400 | $13,369 | 30.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 33 | 137 | $27,537 | $11,587 | 42.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 18 | 20 | $5,340 | $2,202 | 41.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $5,488 | $2,176 | 39.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 33 | $4,587 | $1,829 | 39.9% |
About Dr. Ebere Chukwu, MD
Dr. Ebere Chukwu, MD is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Temple, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093908535.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ebere Chukwu, MD has received a total of $111,638 in payments from pharmaceutical and medical device companies, with $6,332 received in 2024. These payments were reported across 202 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($89,825).
As a Medicare-enrolled provider, Chukwu has provided services to 571 Medicare beneficiaries, totaling 1,149 services with total Medicare billing of $99,253. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Other Specialties Advanced Heart Failure and Transplant Cardiology
- Location Temple, TX
- Active Since 08/18/2007
- Last Updated 01/13/2021
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1093908535
Products in Payments
- JARDIANCE (Drug) $49,256
- ONPATTRO (Drug) $22,190
- AMVUTTRA (Drug) $21,682
- HeartWare HVAD (Device) $1,078
- Impella (Device) $897.11
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $643.93
- HeartMate 3 Left Ventricular Dev (Device) $460.25
- Barostim Neo System (Device) $383.23
- CardioMEMS HF System (Device) $332.69
- VYNDAQEL (Drug) $263.14
- ENTRESTO (Drug) $176.22
- Wegovy (Drug) $139.44
- Ozempic (Drug) $125.92
- VERQUVO (Drug) $115.39
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $104.71
- LOKELMA (Drug) $101.32
- FARXIGA (Drug) $87.17
- CRM-Research only (Device) $73.43
- CARDIOMEMS (Device) $67.91
- Rybelsus (Drug) $40.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.